Shining a light on cancer

We are developing a multi-cancer platform powered by our Dxcover AI Engine, with first application in earlier diagnosis of brain tumours.

The Dxcover Platform has been developed to enable earlier detection of cancer.

 
Chroma-Background_02.jpg

OUR MISSION

To be a world leader in liquid biopsy and artificial intelligence for early detection  of cancers and other diseases to improve survival and quality of life.

From the Newsroom

90%

 OF PATIENTS SURVIVE WHEN CANCER IS FOUND EARLY. EARLY DIAGNOSIS BEATS CANCER.  

Reference - CRUK Statistics impact of early diagnosis

13/07/21

The future of cancer diagnostics is now

We were delighted to speak to Health Tech World recently about the future of cancer diagnostics. “Hailed as the future of cancer...

29/06/21

Dxcover Limited appoints Operations Director

Dxcover Limited has appointed experienced diagnostics industry professional Dr David Eustace as Operations Director to drive product...

18/06/21

ClinSpec Diagnostics rebrands as Dxcover and targets growth

Dxcover Limited is the new name for the cancer diagnostics company formerly known as ClinSpec Diagnostics. ClinSpec Diagnostics, the...